SEC Form 4/A · accession 0001053369-15-000030
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Ashok G Nigalaye
Director · 10% Owner
Period of report
Apr 23, 2015
Accepted (ET)
May 13, 2015 · 7:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3,F2 | Apr 23, 2015 | J | 19,275,135 | $0.00 | A | 38,442,230 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition of common stock to its members.
- F2Ashok Nigalaye is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which was a 10% owner of the issuer, and also serves as a director of the issuer. Reporting person received these securities pursuant to a distribution by EI to members of Epic Pharma, LLC.
- F3In the original filing, the number of shares acquired was under reported by two shares and there was an addition error in the total number of shares owned. This amended filing corrects both of these numbers.